The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
A key highlight will be Brenntag’s qualified amino acids portfolio
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
The said inspection concluded with Zero Form 483 observation
This integrated center combines development, testing, evaluation, and industry-academia-research collaboration
Subscribe To Our Newsletter & Stay Updated
